Pharmaceutical anti-TNF-alpha antibody formulation

Details for Australian Patent Application No. 2003267744 (hide)

Owner Abbott Biotechnology Ltd.

Inventors Baust, Lisa; Krause, Hans-Juergen; Dickes, Michael

Agent Spruson & Ferguson

Pub. Number AU-B-2003267744

PCT Number PCT/IB03/04502

PCT Pub. Number WO2004/016286

Priority 10/222,140 16.08.02 US

Filing date 15 August 2003

Wipo publication date 3 March 2004

Acceptance publication date 12 February 2009

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 9/19 (2006.01) Medicinal preparations characterised by special physical form - lyophilised

Event Publications

8 January 2004 Complete Application Filed

  Priority application(s): 10/222,140 16.08.02 US

22 April 2004 Application Open to Public Inspection

  Published as AU-B-2003267744

12 February 2009 Application Accepted

  Published as AU-B-2003267744

11 June 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003267745-CONTROL SYSTEM FOR CONTROLLING THE FEEDING AND BURNING OF A PULVERIZED FUEL IN A GLASS MELTING FURNACE

2003267743-A FUEL OIL ADDITIVE COMPRISING ALKALINE-EARTH METAL SALTS OF ALKYLBENZENE SULPHONIC ACID